Octopus Robots Aktie
| 0,10EUR | -0,31EUR | -75,49% |
WKN DE: A2JGS9 / ISIN: FR0013310281
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 0 | 0 | 0 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 1 | 1 | 1 | 1 | 0 |
| Summe Anlagevermögen | 1 | 1 | 1 | 0 | 0 |
| Summe Aktiva | 2 | 2 | 2 | 1 | 0 |
Bilanz (in Mio. EUR) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 2 | 2 | 3 | 1 | 1 |
| Summe Eigenkapital | 0 | -1 | -1 | 0 | -1 |
| Summe Passiva | 2 | 2 | 2 | 1 | 0 |
Adresse
| 9, rue du Danemark, 56400 Auray | |
| Telefon | +33 (2) 90-38-01-80 |
| Internet | http://www.octopusbiosafety.com |
Management
|
Antoine Ullens de Schooten Whettnall
Director |
|
Bertrand Vergne
Chairman & Chief Executive Officer |
|
Dorian Pierre
Chief Technology Officer |
|
Frédéric Ullens de Schooten Whettnall
Director |
|
Lancelot Ullens de Schooten Whettnall
Director |
|
Lucile Barthelemy
Chief Marketing Officer |
|
Élodie Giroux
Chief Operating Officer |